Henry Schein Inc (HSIC) is a publicly traded Healthcare sector company. As of May 20, 2026, HSIC trades at $73.17 with a market cap of $8.28B and a P/E ratio of 23.93. HSIC moved +0.36% today. Year to date, HSIC is -5.08%; over the trailing twelve months it is +1.50%. Its 52-week range spans $60.56 to $89.29. Analyst consensus is buy with an average price target of $87.43. Rallies surfaces HSIC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Henry Schein Inc (HSIC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HSIC moved +0.36% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $73.17 |
| Market Cap | $8.28B |
| P/E Ratio | 23.93 |
| EPS | $3.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.29 |
| 52-Week Low | $60.56 |
| Volume | 792.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $12.67B |
| Net Income | $398.00M |
| Gross Margin | 31.69% |
16 analysts cover HSIC: 0 strong buy, 8 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $87.43.